Lincocin Sterile Solution

País: Irlanda

Idioma: inglés

Fuente: HPRA (Health Products Regulatory Authority)

Ingredientes activos:

Lincomycin hydrochloride

Disponible desde:

Zoetis Belgium S.A.

Código ATC:

QJ01FF02

Designación común internacional (DCI):

Lincomycin hydrochloride

Dosis:

100 milligram(s)/millilitre

formulario farmacéutico:

Solution for injection

tipo de receta:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupo terapéutico:

Cats, Dogs, Pigs

Área terapéutica:

lincomycin

indicaciones terapéuticas:

Antibacterial

Estado de Autorización:

Authorised

Fecha de autorización:

2014-10-10

Ficha técnica

Health Products Regulatory Authority
14 July 2017
CRN000TZQ
Page 1 of 4
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Lincocin Sterile Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active Substance
Lincomycin 100 mg
(as Lincomycin Hydrochloride)
Excipients
Benzyl alcohol 9 mg For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear colourless aqueous sterile solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs, cats and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Dogs and cats : for the treatment of infections caused by
Gram-positive organisms
which are sensitive to linocomycin, particularly streptococci and some
anaerobic
bacteria.
Pigs : for the treatment of infections caused by Gram-positive
bacteria, some
anaerobic bacteria and mycoplasma sensitive to lincomycin.
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredient.
Do not use in animals with known pre-existing monilial infection.
Concurrent treatment with erythromycin is not recommended.
Not for use in species other than dog, cat or pig. Do not administer
to rabbits,
hamsters, guinea pigs, chinchillas, horses or ruminants as this could
result in severe
gastro-intestinal disturbance.
Health Products Regulatory Authority
14 July 2017
CRN000TZQ
Page 2 of 4
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
If the intravenous route is used in dogs and cats, the injection
should be made slowly.
Do not use against _E. Coli_, Salmonella spp., _Enterococcus faecalis
_or yeasts.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Avoid contact with the product. In case of accidental eye or skin
contact, wash off the
affected area thoroughly with water.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Not applicable.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
No restrictions.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUC